A LETTER TO PACIRA BIOSCIENCES SHAREHOLDERS FROM DOMA PERPETUAL CAPITAL MANAGEMENT LLC

Impact · against what's priced in

The entry of DOMA Perpetual as an activist shareholder introduces a catalyst for a strategic sale and governance changes, which may create a price floor for PCRX. However, this is tempered by the activist's specific allegations of 'gross negligence' regarding the management of EXPAREL's patent litigation risks, which increases the perceived risk of a catastrophic loss of the core asset.

PCRX+0.20

No priced-in read yet